CD34 and myelodysplastic syndrome: To determine the dysregulated molecular pathways associated with mutated RUNX1, we compared the expression profiles of CD34 + cells of LR-MDS patients with (mutR-LR) and without (wtR-LR) RUNX1 mutations.